#de novo molecular design
Discover 3 curated intelligence briefings related to this specific topic.
The Air-to-Protein Pivot: Why This Month’s Lab Breakthroughs are Redefining Food Security
September 2026 marks a critical inflection point in food technology. With massive capital injections into AI-powered fermentation and a strategic shift toward regional waste-stream utilization in Ghana, the industry is moving beyond the plant-based hype toward a resilient, decoupled protein infrastructure.
Sequence-to-Function Modeling Ends the Trial-and-Error Era of Gene Delivery
High-density guide on implementing context-aware models and genome-scale atlases to eliminate the stochasticity of in-vivo gene delivery and CAR T pharmaceuticalization.
Generative Chemistry Just Broke the Lab Bottleneck
The surge in de novo molecular design, powered by $400M infusions and quantum-enhanced AI, has created a critical divergence: software is designing drugs and polymers at a velocity that physical labs and manufacturing plants cannot match.